NOTE 12 - SEGMENTS (Details) - USD ($) |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
Revenues | $ 1,150,719 | $ 614,456 |
Worlds 3D | ||
Revenues | 61 | 213 |
Depreciation and amortization | ||
Loss before taxes | (138,023) | (132,521) |
Capital expenditures | ||
Assets | 4,576 | 20,311 |
MariMed Advisors | ||
Revenues | 1,150,658 | 614,243 |
Depreciation and amortization | 69,827 | 35,439 |
Loss before taxes | 247,409 | 70,759 |
Capital expenditures | 1,806,655 | 990,504 |
Assets | $ 10,845,183 | $ 5,368,004 |
X | ||||||||||
- Definition Amount of significant additions in the period in other assets (current, noncurrent, or unclassified). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount recognized in net periodic benefit cost and other comprehensive income. No definition available.
|
X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|